Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux - Guerin, Maryse; Egger, Pascal; Soudant, Céline; Le Goff, Wilfried; van Tol, Arie; Dupuis, Reynald; Chapman, M. John (Atherosclerosis (00219150), 2002)